The American Board of Medical Specialties (ABMS) announced this week the recognition of Addiction Medicine as a new subspecialty.
“This is a great day for addiction medicine,” said Robert J. Sokol, MD, president of the American Board of Addiction Medicine (ABAM) and The Addiction Medicine Foundation. “This landmark event, more than any other, recognizes addiction as a preventable and treatable disease, helping to shed the stigma that has long plagued it. It sends a strong message to the public that American medicine is committed to providing expert care for this disease and services designed to prevent the risky substance use that precedes it.”
The American Board of Preventive Medicine (ABPM), a Member Board of ABMS, sponsored the application for the new field to be a multispecialty subspecialty—meaning that physicians certified by any Member Board of the ABMS can become certified in Addiction Medicine. The ABMS subspecialty recognition of Addiction Medicine was championed by the ABAM, which has established a certification examination and Maintenance of Certification (MOC) process for addiction medicine physicians.
“This recognition by ABMS will help assure patients and their families that the care they receive is grounded in science and evidence-based practice,” added Patrick G. O’Connor, MD, MPH, immediate past president of ABAM, who worked closely with APBM and the ABMS Member Boards to help achieve this landmark event. “It will also mean more visibility for this subspecialty among medical students and residents, and will ultimately increase the number of physicians who are trained and certified as addiction medicine specialists.”
Back to March 17, 2016 Medigram